Expression of SOCS-1, suppressor of cytokine signalling-1, in human melanoma

Journal of Investigative Dermatology

Volumn 123, Issue 4, 2004, Pages 737-745

  Li, Zhuo ^a   Metze, Dieter ^a   Nashan, Dorothea ^a   Müller Tidow, Carsten ^a   Serve, Hubert L ^a   Poremba, Christopher ^b   Luger, Thomas A ^a   Böhm, Markus ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cytokine resistance; Interferon; Interleukin 6; Melanoma; Suppressor of cytokine signalling

Indexed keywords

INTERFERON; INTERLEUKIN 6; MESSENGER RNA; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CELL STRAIN; CELL STRAIN WM 35; CELL STRAIN WM 9; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; MELANOMA; MELANOMA CELL; NEVUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

EID: 4644278484     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.23408.x     Document Type: Article

References (48)

1. Aso T, Lane WS, Conaway JW, Conaway RC: Elongin (SIII): A multisubunit regulator of elongation by RNA polymerase II. Science 269:1439-1443, 1995
2. RSK as the probable CREB-Ser133 kinase in human melanocytes. Cell Growth Differ 6:291-302, 1995
3. Böhm M, Möller P, Kalbfleisch U, Worm M, Czarnetzki BM, Schadendorf D: Lysis of allogeneic and autologous melanoma cells by IL-7-induced lymphokine-activated killer cells. Br J Cancer 70:54-59, 1994
4. Böhm M, Schulte U, Funk JO, et al: Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activity. J Invest Dermatol 117:132-140, 2001
5. Böhm M, Schiller M, Ständer S, et al: Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. J Invest Dermatol 118: 533-539, 2002
6. Bradsher JN, Jackson KW, Conaway RC, Conaway JW: RNA polymerase II transcription factor SIII. I. Identification, purification, and properties. J Biol Chem 268:25587-25593, 1993a
7. Bradsher JN, Tan S, McLaury HJ, Conaway JW, Conaway RC: RNA polymerase II transcription factor SIII. II. Functional properties and role in RNA chain elongation. Biol Chem 268:25594-256035, 1993
8. Brender C, Nielsen M, Ropke C, et al: Interferon-alpha induces transient suppressors of cytokine signalling expression in human T cells. Exp Clin Immunogenet 18:80-85, 2001
9. Chen XP, Losman JA, Cowan S, et al: Pim serine/threonine kinases regulate the stability of Socs-1 protein. Proc Natl Acad Sci USA 99:2175-2180, 2002
10. Duan DR, Pause A, Burgess WH, et al: Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 269:1402-1406, 1995
11. Eggermont AM: The role interferon-alpha in malignant melanoma remains to be defined. Eur J Cancer 37:2147-2153, 2001
12. Endo TA, Masuhara M, Yokouchi M, et al: A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921-924, 1997
13. Federici M, Giustizieri ML, Scarponi C, Girolomoni G, Albanesi C: Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1. J Immunol 169:434-442, 2002
14. Florenes VA, Lu C, Bhattacharya N, Rak J, Sheehan C, Slingerland JM, Kerbel RS: Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma. Oncogene 18:1023-1032, 1999
15. Garrett KP, Aso T, Bradsher JN, Foundling SI, Lane WS, Conaway RC, Conaway JW: Positive regulation of general transcription factor SIII by a tailed ubiquitin homolog. Proc Natl Acad Sci USA 92:7172-7176, 1995
16. Garrett KP, Tan S, Bradsher JN, Lane WS, Conaway JW, Conaway RC: Molecular cloning of an essential subunit of RNA polymerase II elongation factor SIII. Proc Natl Acad Sci USA 91:5237-5241, 1994
17. Hanada T, Yoshida T, Kinjyo I, et al: A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box. J Biol Chem 276:40746-40754, 2001
18. Iwamoto T, Senga T, Naito Y, Matsuda S, Miyake Y, Yoshimura A, Hamaguchi M: The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation. Oncogene 19:4795-4801, 2000
19. Kamura T, Sato S, Haque D, Liu L, Kaelin WG, Conaway RC, Conaway JW: The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Develop 12:3872-3881, 1998
20. Kerbel RS: Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Am J Pathol 141:519-524, 1993
21. Kibel A, Iliopoulos O, DeCaprio JA, Kaelin WG Jr: Binding of the von Hippel-Undau tumor suppressor protein to Elongin B and C. Science 269:1444-1446, 1995
22. Kortylewski M, Heinrich PC, Mackiewicz A, et al: Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1. Oncogene 18:3742-3753, 1999
23. Krebs DL, Hilton DJ: SOCS: Physiological suppressors of cytokine signaling. J Cell Sci 113:2813-2819, 2000
24. Legha SS: The role of interferon alpha in the treatment of metastatic melanoma. Semin Oncol 24 (Suppl. 4):S23-S31, 1997
25. Lu C, Kerbel RS: Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J Cell Biol 120:1281-1288, 1993
26. Lu C, Rak JW, Kobayashi H, Kerbel RS: Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions. Cancer Res 53:2708-2711, 1993
27. Lu C, Vickers MF, Kerbel RS: Interleukin 6 a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. Proc Natl Acad Sci USA 89:9215-9219, 1992
28. Magrangeas F, Boisteau O, Denis S, Jacques Y, Minvielle S: Negative regulation of onconstatin M signaling by suppressor of cytokine signaling (SOCS-3). Eur Cytokine Netw 12:309-315, 2001
29. Milling SW, Silvers WK, Sai T, Mintz B: Decline in MHC class I expression with increasing thickness of cutaneous melanomas in standard-strain transgenic mouse models. Melanoma Res 12:221-230, 2002
30. Mortarini R, Belli F, Parmiani G, Anichini A: Cytokine-mediated modulation of HLA-class II, ICAM-1, LFA-3 and tumor-associated antigen profile of melanoma cells. Comparison with anti-proliferative activity by rIL1-beta, rTNF-alpha, rIFN-gamma, rIL4 and their combinations. Int J Cancer 45:334-341, 1990
31. Müller C, Readhead C, Diederichs S, et al: Methylation of the cyclin A1 promoter correlates with gene silencing in somatic cell lines, while tissue-specific expression of cyclin A1 is methylation independent. Mol Cell Biol 20: 3316-3329, 2000
32. Munro S, Pelham HR: An Hsp 70-like protein in the ER: Identity with the 78 kD glucose-regulated and immunoglobulin heavy chain binding protein. Cell 46:291-300, 1986
33. Naka T, Narazaki M, Hirata M, et al: Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924-929, 1997
34. Narazaki M, Fujimoto M, Matsumoto T, et al: Three distinct domains of SSI-1/ SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling. Proc Natl Acad Sci USA 95:13130-13134, 1998
35. Nicholson SE, Willson TA, Farley A, et al: Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J 18:375-385, 1999
36. Nistico P, Tecce R, Giacomini R Cavallari A, D'Agnano I, Fisher PB, Natali PG: Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells. Cancer Res 50:7422-7429, 1990
37. Novak U, Marks D, Nicholson SE, Hilton D, Paradis L: Differential ability of SOCS proteins to regulate IL-6 and CSF-1 induced macrophage differentiation. Growth Factors 16:305-314, 1999
38. Raccurt M, Tam SP, Lau P, et al: Suppressor of cytokine signalling gene expression is elevated in breast carcinoma. Br J Cancer 89:524-532, 2003
39. Rodeck U, Bossler A, Graeven U, Fox FE, Nowell PC, Knabbe C, Kari C: Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells. Cancer Res 54:575-581, 1994
40. Sakamoto H, Yasukawa H, Masuhara M, et al: A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons. Blood 92:1668-1676, 1998
41. Siewert E, Muller-Esterl W, Starr R, Heinrich PC, Schaper F: Different protein turnover of interleukin-6-type cytokine signalling components. Eur J Biochem 265:251-257, 1999
42. Song MM, Shual K: The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J Biol Chem 273:35056-35062, 1998
43. Starr R, Willson TA, Viney EM, et al: A family of cytokine-inducible inhibitors of signalling. Nature 387:917-921, 1997
44. Swope VB, Abdel-Malek Z, Kassem LM, Nordlund JJ: Interleukins 1 alpha and 6 and tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J Invest Dermatol 96:180-185, 1991
45. Vaux D, Tooze J, Fuller S: Identification by anti-idiotype antibodies of an intracellular membrane protein that recognizes a mammalian endoplasmic reticulum retention signal. Nature 345:495-502, 1990
46. Wong LH, Krauer KG, Hatzinisiriou I, et al: Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3 gamma. J Biol Chem 272:28779-28785, 1997
47. Yasukawa H, Sasaki A, Yoshimura A: Negative regulation of cytokine signaling pathways. Ann Rev Immunol 18:143-164, 2000
48. Zhang JG, Parley A, Nicholson SE, et al: The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound to proteins to proteasomal degradation. Proc Natl Acad Sci USA 96:2071-2076, 1999